Navigation Links
Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
Date:1/6/2012

SAN DIEGO, Jan. 6, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 30th Annual J. P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California.   

The corporate presentation will review the Company accomplishments in 2011, as well as outline the corporate plans for 2012 and beyond.

Specifically, the Company will discuss the recent very productive Type C meeting that was held with the FDA on elagolix for endometriosis, one of the outcomes of which was the decision to file a Special Protocol Assessment (SPA) with the FDA. The expected NDA filing of elagolix for the treatment of endometriosis is in 2015.

Additionally, the presentation will cover the Company's VMAT2 program for movement disorders, including the status of the current Phase II study assessing the impact of NBI-98854 in patients with tardive dyskinesia. This study, which began in the fall of 2011, has recently completed enrollment and will report top-line data in the first quarter of 2012.  The Company also recently received a notification of allowable claims for its NBI-98854 European Patent Application from the European Patent Office, and has begun planning for larger Phase IIb trials, to be launched in mid-2012, for up to three months of continuous treatment with NBI-98854.

 

The live presentation takes place on Thursday, January 12, 2012 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.  A copy of the presentation materials will be filed with the Securities and Exchange Commission on or before Monday, January 9, 2012.

If you
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference
2. Neurocrine Biosciences to Present at the 2011 Credit Suisse Annual Health Care Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
4. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
5. Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
6. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
7. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
8. Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
10. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
11. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... David A. Ramsay as ... Vice President, Corporate Development at Halozyme. ... his established financial management experience and his recent ... our commercial group for the last four years, ...
(Date:5/23/2013)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), ... present a company overview at the Deutsche Bank 38 th ... 2013 at 8:40 a.m. ET in Boston, MA. ... presentation will be available on the "Investors & Media" section ... will be available on the Isis Web site within 48 ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... with the National Institute of Allergy and ... biodefense,research, under which the NIAID will conduct ... as a treatment for,anthrax and other high-priority ...
... Compound, AHLi-11, Slated for IND Filing By ... ... Quark Pharmaceuticals, Inc., a,clinical-stage biopharmaceutical company focused on discovering and,developing novel ... the State University of New York at,Buffalo, Center for Hearing & ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 2Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 3Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 4
(Date:5/23/2013)... Tickets announces that Paul McCartney will be performing ... This well known ticket website has slashed prices across ... fans see Sir Paul live in concert. Jan, the ... offering the customer appreciation code SAVE for additional savings on ... also a huge McCartney fan and plans to see him ...
(Date:5/23/2013)... (HealthDay News) -- Schools should ensure that kids ... each day to support their health and boost ... Although previous studies show 60 minutes ... and development, it,s estimated that only about 50 ... recommendation, according to the report from the Institute ...
(Date:5/23/2013)... (HealthDay News) -- Symptoms of borderline personality disorder ... diagnosis and treatment. But researchers in Canada say ... unique to borderline personality disorder: a tendency to ... "They have difficulty processing facial emotions and will ... said Anthony Ruocco, a clinical neuropsychologist and assistant ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) ... as badly as methamphetamine or crack cocaine, a new ... ,meth mouth, or ,coke mouth, it is startling to ... less the same," said Dr. Mohamed Bassiouny, a professor ... Dentistry in Philadelphia. Methamphetamine, crack cocaine and soda ...
(Date:5/23/2013)... News) -- Although a study in 2012 suggested ... memory problems associated with Alzheimer,s disease, three groups ... to duplicate those findings. The teams said ... safety since the drug involved in the study, ... major blood-lipid abnormalities, pancreatitis, headaches, fatigue, weight gain, ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2
... ANN ARBOR, Mich. Head and neck cancer patients ... more symptoms of chronic pain and complaints of dry mouth ... the University of Michigan Comprehensive Cancer Center. Because these ... that reducing these factors in head and neck cancer patients ...
... touchscreens, housed in computer kiosks at clinics and ... School of Medicine and clinicians at local health ... diverse language, literacy and computer skills. The ... and collect patient data. Each piece of text ...
... Gordon HealthDay Reporter , FRIDAY, July 9 (HealthDay ... and well-being of America,s children, a group of 22 federal ... pregnancies in particular, but bad news in other areas, like ... is a status update on how our nation,s children are ...
... Researchers at Brown University have found that the length of ... doubled during the last 10 years. The study, which will ... the American Geriatrics Society , evaluated hospice use in U.S. ... treatment time has increased from 46 to 93 days. The ...
... ... used cosmetic lasers and other used aesthetic equipment by more than 30% to meet the ... to their patients. , ... Ft. Lauderdale, FL (PRWEB) July 9, 2010 -- The Laser Warehouse has increased its ...
... ... in 2002, the association has accredited certification bodies that represent more than ... Medical Sales Representatives) RMSR Certification has been recently cited with the U. ... sole approved accreditor of certification bodies for entry level Medical Device & ...
Cached Medicine News:Health News:Pain, dry mouth may play role in sleep quality of head and neck cancer patients 2Health News:Pain, dry mouth may play role in sleep quality of head and neck cancer patients 3Health News:Talking touchscreens aid patients 2Health News:U.S. Report on Kids' Health Brings Mixed Results 2Health News:U.S. Report on Kids' Health Brings Mixed Results 3Health News:Study: Medicare policy may account for growing length of hospice stays in nursing homes 2Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 2Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 3Health News:RMSR Certification Gains Medical Device & Equipment Industry Acceptance for Medical Sales Reps 2Health News:RMSR Certification Gains Medical Device & Equipment Industry Acceptance for Medical Sales Reps 3